A detailed history of Federated Hermes, Inc. transactions in Schrodinger, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 5,400 shares of SDGR stock, worth $138,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,400
Previous 5,400 -0.0%
Holding current value
$138,618
Previous $104,000 3.85%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$24.74 - $35.13 $34,636 - $49,182
1,400 Added 35.0%
5,400 $145,000
Q3 2023

Nov 13, 2023

SELL
$27.34 - $55.37 $164,040 - $332,220
-6,000 Reduced 60.0%
4,000 $113,000
Q2 2023

Aug 14, 2023

SELL
$26.1 - $49.92 $1.33 Million - $2.54 Million
-50,956 Reduced 83.59%
10,000 $499,000
Q1 2023

May 08, 2023

SELL
$18.09 - $27.61 $29,776 - $45,446
-1,646 Reduced 2.63%
60,956 $1.6 Million
Q4 2022

Feb 13, 2023

BUY
$16.24 - $26.38 $290,631 - $472,096
17,896 Added 40.03%
62,602 $1.17 Million
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $950,503 - $1.38 Million
39,687 Added 790.74%
44,706 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$21.39 - $35.9 $157,473 - $264,295
-7,362 Reduced 59.46%
5,019 $133,000
Q1 2022

May 13, 2022

BUY
$24.84 - $36.12 $307,544 - $447,201
12,381 New
12,381 $422,000
Q4 2020

Feb 12, 2021

SELL
$48.06 - $84.4 $68,389 - $120,101
-1,423 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$46.87 - $93.33 $1.16 Million - $2.32 Million
-24,814 Reduced 94.58%
1,423 $68,000
Q2 2020

Aug 13, 2020

SELL
$36.12 - $91.57 $858,319 - $2.18 Million
-23,763 Reduced 47.53%
26,237 $2.4 Million
Q1 2020

May 13, 2020

BUY
$26.6 - $52.99 $1.33 Million - $2.65 Million
50,000 New
50,000 $2.16 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.59B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.